BMS-986207 for Non-Small Cell Lung Cancer
This trial will test a new cancer treatment involving a combination of drugs. The goal is to see if it is safe and effective for people with stage IV non-small cell lung cancer.
- Non-Small Cell Lung Cancer
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the BMS-986207 research landscape?
"BMS-986207 was first studied a decade ago, in 2009, at Texas Children's Hospital. To date, there have been 18638 completed trials worldwide. Currently, 796 clinical trials are still running; many of which are based in Orange City, Kentucky."
Which patients does BMS-986207 help the most?
"BMS-986207 has shown to be effective in the treatment of malignant neoplasms, unresectable melanoma, and previous anti-angiogenic therapy."
Are volunteers still being accepted for this experiment?
"Yes, this is an ongoing study that is currently seeking patients. The trial was first posted on October 3rd, 2020 and has since been updated November 15th, 2020. A total of 180 individuals are needed to be recruited from 19 different locations."
How many people are part of this clinical trial?
"That is correct, the information available on clinicaltrials.gov suggests that this trial is seeking new participants. The first posting was on October 3rd, 2020 and there have been edits made as recently as November 15th, 2020. In total, the study needs to enrol 180 patients from 19 different sites."
Are there any risks associated with taking BMS-986207?
"BMS-986207 is still being tested for efficacy in Phase 2 trials, but there is some data supporting its safety which landed it a score of 2."
In how many different places is this clinical trial being performed?
"This clinical trial has 20 locations, with the primary operating centres being Saint Alphonsus Regional Medical Center in Orange City, Kentucky, Mid Florida Hematology and Oncology Center in Edgewood, Idaho, and Compassionate Cancer Care Medical Group in Boise, New York."